03/21/23 6:13 AMNasdaq, NYSE : ZURA, JATT, JATTU acquisitionlow floatZura Bio Limited Announces Closing of Business Combination with JATT Acquisition CorpZura Bio Limited, a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, today announced the closing of its business combination with JATT Acquisition Corp, a special purpose acquisition company, on March 20, 2023. Upon the completion of the business combination, JATT changed its...RHEA-AIneutral
03/16/23 4:17 PMNYSE : JATT acquisitionlow floatJATT Acquisition Corp Shareholders Approve Proposed Business Combination with Zura Bio LimitedJATT Acquisition Corp, a publicly traded special purpose acquisition company, today announced that its shareholders voted to approve its proposed business combination with Zura Bio Limited, a clinical-stage biotechnology company. At the closing of the business combination, which is expected to occur on March 20, 2023, after all closing conditions are...RHEA-AIneutral
03/13/23 9:28 AMNYSE : JATT acquisitionlow floatJATT Acquisition Corp Announces Planned Transfer of Listing to NASDAQ in Connection with its Proposed Business Combination with Zura Bio LimitedJATT Acquisition Corp, a publicly-traded special purpose acquisition company, today announced that it will voluntarily transfer the listing of its Class A ordinary shares, public warrants and units from the New York Stock Exchange to the Nasdaq Stock Market LLC in connection with, and upon the closing of, the previously announced business combination with...RHEA-AIneutral
03/02/23 7:02 AMNYSE : JATT acquisitionlow floatJATT Acquisition Corp’s Proposed Business Combination With Zura Bio Limited Declared Effective by US SECJATT Acquisition Corp, the publicly traded special purpose acquisition company, has today announced that the U.S. Securities and Exchange Commission has declared its registration statement on Form S-4 pertaining to the proposed business combination with Zura Bio Limited as effective. Zura is a UK based multi-asset clinical-stage biotechnology company...RHEA-AIneutral
06/17/22 7:00 AMNYSE : JATT acquisitionlow floatJATT Acquisition Corp. and Zura Bio Limited Announce Definitive Business Combination Agreement to Create NYSE Listed Biotechnology CompanyZura Bio Limited, a clinical-stage biotechnology company focused...RHEA-AIneutral
09/03/21 7:44 AMNYSE : JATT, U acquisitionlow floatJATT Acquisition Corp Announces that its Ordinary Shares and Warrants will Commence Separate Trading on or about September 3, 2021Each unit consists of one ordinary share and one-half of one redeemable warrant, with each whole warrant entitling the holder to purchase one ordinary share at a price of $11.50 per share. Holders of units will need to have their brokers contact Continental Stock Transfer& Trust Company, the Company's transfer agent, in order to separate the units into ordinary...RHEA-AIneutral
